CORRECTED-Valeant to buy Bausch & Lomb for $8.7 billion

Mon May 27, 2013 8:30am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

(Fixes ticker in first line of story)
    TORONTO, May 27 (Reuters) - Valeant Pharmaceuticals
International Inc said on Monday that it had inked an
$8.7 billion cash deal to take over eye health company Bausch &
Lomb Holdings.
    The deal, to be financed through debt and equity, will see
some $4.5 billion go to an investor group led by Warburg Pincus
LLC, with some $4.2 billion used to pay down Bausch & Lomb's
outstanding debt.

 (Reporting by Julie Gordon; Editing by David Cowell)